IBDEI2S1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44285,2)
 ;;=^5003130
 ;;^UTILITY(U,$J,358.3,44286,0)
 ;;=F11.229^^164^2192^20
 ;;^UTILITY(U,$J,358.3,44286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44286,1,3,0)
 ;;=3^Opioid Intox w/o Percep Disturb w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,44286,1,4,0)
 ;;=4^F11.229
 ;;^UTILITY(U,$J,358.3,44286,2)
 ;;=^5003132
 ;;^UTILITY(U,$J,358.3,44287,0)
 ;;=F11.929^^164^2192^21
 ;;^UTILITY(U,$J,358.3,44287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44287,1,3,0)
 ;;=3^Opioid Intox w/o Percep Disturb w/o Use D/O
 ;;^UTILITY(U,$J,358.3,44287,1,4,0)
 ;;=4^F11.929
 ;;^UTILITY(U,$J,358.3,44287,2)
 ;;=^5003146
 ;;^UTILITY(U,$J,358.3,44288,0)
 ;;=F11.122^^164^2192^17
 ;;^UTILITY(U,$J,358.3,44288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44288,1,3,0)
 ;;=3^Opioid Intox w/ Percep Disturb w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,44288,1,4,0)
 ;;=4^F11.122
 ;;^UTILITY(U,$J,358.3,44288,2)
 ;;=^5003117
 ;;^UTILITY(U,$J,358.3,44289,0)
 ;;=F11.222^^164^2192^18
 ;;^UTILITY(U,$J,358.3,44289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44289,1,3,0)
 ;;=3^Opioid Intox w/ Percep Disturb w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,44289,1,4,0)
 ;;=4^F11.222
 ;;^UTILITY(U,$J,358.3,44289,2)
 ;;=^5003131
 ;;^UTILITY(U,$J,358.3,44290,0)
 ;;=F11.922^^164^2192^19
 ;;^UTILITY(U,$J,358.3,44290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44290,1,3,0)
 ;;=3^Opioid Intox w/ Percep Disturb w/o Use D/O
 ;;^UTILITY(U,$J,358.3,44290,1,4,0)
 ;;=4^F11.922
 ;;^UTILITY(U,$J,358.3,44290,2)
 ;;=^5003145
 ;;^UTILITY(U,$J,358.3,44291,0)
 ;;=F11.99^^164^2192^23
 ;;^UTILITY(U,$J,358.3,44291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44291,1,3,0)
 ;;=3^Opioid Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,44291,1,4,0)
 ;;=4^F11.99
 ;;^UTILITY(U,$J,358.3,44291,2)
 ;;=^5133352
 ;;^UTILITY(U,$J,358.3,44292,0)
 ;;=F11.21^^164^2192^27
 ;;^UTILITY(U,$J,358.3,44292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44292,1,3,0)
 ;;=3^Opioid Use DO,Mod/Sev,In Remiss
 ;;^UTILITY(U,$J,358.3,44292,1,4,0)
 ;;=4^F11.21
 ;;^UTILITY(U,$J,358.3,44292,2)
 ;;=^5003128
 ;;^UTILITY(U,$J,358.3,44293,0)
 ;;=Z79.891^^164^2192^1
 ;;^UTILITY(U,$J,358.3,44293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44293,1,3,0)
 ;;=3^Long Term Opiate/Opioid Analgesic Use
 ;;^UTILITY(U,$J,358.3,44293,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,44293,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,44294,0)
 ;;=F11.11^^164^2192^24
 ;;^UTILITY(U,$J,358.3,44294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44294,1,3,0)
 ;;=3^Opioid Use DO,Mild,In Remiss
 ;;^UTILITY(U,$J,358.3,44294,1,4,0)
 ;;=4^F11.11
 ;;^UTILITY(U,$J,358.3,44294,2)
 ;;=^268246
 ;;^UTILITY(U,$J,358.3,44295,0)
 ;;=F13.180^^164^2193^1
 ;;^UTILITY(U,$J,358.3,44295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44295,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Anxiety D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,44295,1,4,0)
 ;;=4^F13.180
 ;;^UTILITY(U,$J,358.3,44295,2)
 ;;=^5003197
 ;;^UTILITY(U,$J,358.3,44296,0)
 ;;=F13.280^^164^2193^2
 ;;^UTILITY(U,$J,358.3,44296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44296,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Anxiety D/O w/ Mod-Sev Use D/O
 ;;^UTILITY(U,$J,358.3,44296,1,4,0)
 ;;=4^F13.280
 ;;^UTILITY(U,$J,358.3,44296,2)
 ;;=^5003216
 ;;^UTILITY(U,$J,358.3,44297,0)
 ;;=F13.980^^164^2193^3
 ;;^UTILITY(U,$J,358.3,44297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44297,1,3,0)
 ;;=3^Sedative/Hypnotic/Anxiolytic Induced Anxiety D/O w/o Use D/O
